How New Therapies Like Ozempic, Jardiance, and Mounjaro Shape Cardiovascular Risk The growing body of evidence highlights how specific branded therapies are shaping cardiovascular outcomes in diabetes: Ozempic (semaglutide): Beyond lowering HbA1c, it reduces major adverse cardiovascular events, supports weight loss, and improves lipid profiles
Davis R, Emmonds SE
Noticeably, Novo Nordisk increased its patenting activity in 2019, two years before Wegovy was approved
People with severe upper abdominal pain, repeated vomiting, yellowing of the eyes, or reduced urination should seek urgent medical attention
They eat less because their brain receives stronger satiety signals, and food moves through their digestive system more slowly, extending the feeling of fullness after meals